Thursday, 11 December, 2025
Inito to Leverage AI-Designed Antibodies for New At-Home Diagnostics
Fertility startup Inito, known for its at-home hormone monitoring system, plans to utilize AI-designed antibodies to expand its suite of health tests. By moving beyond traditional fertility markers, Inito aims to offer a new generation of quantitative, at-home diagnostics for various health conditions, potentially transforming the in-vitro diagnostics (IVD) market.
Read full story at TechCrunch